Tahir Misbah bought MAZE
March 2, 2026 · Form 4 insider transaction
Tahir Misbah bought 20,000 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.; The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date.; These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.